Karen M. Nichols
General Counsel at International Society for Cellular Therapy
Profile
Karen M.
Nichols is currently the Chief Regulatory Officer at the International Society for Cellular Therapy since 2007.
Prior to this, she held the position of Vice President-Regulatory & Quality at NantKwest, Inc. and Magenta Therapeutics, Inc. Ms. Nichols completed her undergraduate and graduate degrees from The State University of New York and also holds a graduate degree from Suffolk University Law School, which was conferred in 1996.
Karen M. Nichols active positions
| Companies | Position | Start |
|---|---|---|
International Society for Cellular Therapy
 International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | General Counsel | 2006-12-31 |
Former positions of Karen M. Nichols
| Companies | Position | End |
|---|---|---|
| MAGENTA THERAPEUTICS | General Counsel | - |
| IMMUNITYBIO, INC. | General Counsel | - |
Training of Karen M. Nichols
| The State University of New York | Graduate Degree |
| Suffolk University Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology NantKwest, Inc. engages in the research and development of immunotherapies. It uses natural killer cells to treat cancer, infectious diseases, and inflammatory diseases. The company was founded by Gary N. Keller and Hans Georg Klingemannon October 7, 2002 and is headquartered in San Diego, CA. | Health Technology |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Commercial Services |
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Karen M. Nichols
